To mark Fragile X awareness day today and the 35th anniversary of the Fragile X Society, Queen’s University and the Fragile X ...
While Harmony management has not disclosed future plans for ZYN002, Jefferies analysts expect the asset to be shelved.
Pharmaceutical Technology on MSN
Servier to acquire potential Fragile X syndrome treatment from Kaerus
Servier has signed a definitive agreement with Kaerus Bioscience to acquire a potential Fragile X syndrome (FXS) treatment, KER-0193.
Zacks Investment Research on MSN
HRMY Stock Down as Fragile X Syndrome Study Fails to Meet Goal
Shares of Harmony Biosciences Holdings, Inc. HRMY lost 16.56% on Sept. 24 after the company announced the failure of the late-stage registrational RECONNECT study on pipeline candidate ZYN002 in ...
Fragile X syndrome, the most common form of inherited intellectual disability, may be unfolding in brain cells even before birth, despite typically going undiagnosed until age 3 or later. A new study ...
Fragile X syndrome (FXS) and autism spectrum disorder (ASD) sometimes occur together. While FXS is a known genetic cause of ASD, not everyone who receives an FXS diagnosis is autistic, and not all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results